| 1. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1134KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 2. |
Reteplase: a new thrombolytic for European markets |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 3-4
Robert Short,
Preview
|
PDF (2142KB)
|
|
摘要:
A new thrombolytic agent for use in patients with myocardial infarction (MI) will soon be available in Europe. Boehringer Mannheim's reteplase, a molecule genetically engineered from human tissue plasminogen activator, was approved in August by the European Medicines Evaluation Agency (EMEA) for use in all European Union countries as a thrombolytic agent for the treatment of acute MI. The Heidelberg symposium, ‘Update in Thrombolysis 1996’ [Heidelberg, Germany; September 1996] provided an opportunity for cardiologists to gauge current thinking on the clinical utility of this agent.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 3. |
Asthma undertreated in a nonselected population in France |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 4-4
&NA;,
Preview
|
PDF (1085KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 4. |
Focus on polio immunisation … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 5-5
&NA;,
Preview
|
PDF (1079KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 5. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1078KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 6. |
Reducing costs by reducing lipid levels in CHD |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 7-8
David B Jack,
Preview
|
PDF (2151KB)
|
|
摘要:
There is now good evidence to support the use of HMG-CoA reductase inhibitors in the primary and secondary prevention of coronary heart disease (CHD). It is thought that the maximum benefit of such treatment can only be obtained with life-long treatment. Since these drugs are expensive, their use is now being scrutinised from a cost-effectiveness point of view, as discussed at the 18th Congress of the European Society of Cardiology (ESC) [Birmingham, UK; August 1996]. As a comparison, the cost-effectiveness of tocopherol [vitamin E] in people with proven atherosclerosis was also discussed.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 7. |
Clarithromycin + omeprazole cuts cost of ulcer treatment |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1119KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 8. |
Topotecan in myelodysplastic syndrome and CMML |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 9-9
&NA;,
Preview
|
PDF (883KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 9. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 10-10
&NA;,
Preview
|
PDF (998KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 10. |
New treatments for bacterial infections at ICAAC |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1060,
1996,
Page 11-12
Gill Higgins,
Preview
|
PDF (2169KB)
|
|
摘要:
Favourable reports of trovafloxacin's antibacterial activity were highlighted by several studies at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) [New Orleans, US; September 1996]. Of particular interest, promising results were seen with the agent in a study involving children with meningitis. Other developments to make the news were the use of berberine to treat diarrhoea in immunocompromised patients, and the discovery of a bacterial protein that could act as an immunogen to protect against infection of surgically implanted plastic devices.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
首页
